SUPPLEMENTAL INDENTURE RELATED TOTHE ASSUMPTION
Exhibit 4.2
SUPPLEMENTAL INDENTURE
RELATED TO THE ASSUMPTION
SUPPLEMENTAL INDENTURE (this Supplemental Indenture) dated as of March 27, 2015, among VALEANT PHARMACEUTICALS INTERNATIONAL, INC., a corporation continued under the British Columbia Business Corporations Act (the Company), the Note Guarantors party hereto (the Guarantors) and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association duly organized under the laws of the United States, as trustee under the Indenture referred to below (the Trustee).
W I T N E S S E T H :
WHEREAS VRX ESCROW CORP., a corporation organized under the federal laws of Canada (the Escrow Issuer) has heretofore executed and delivered to the Trustee an indenture (as amended, supplemented or otherwise modified, the Indenture) dated as of March 27, 2015, providing for the issuance of the Escrow Issuers 5.375% Senior Notes due 2020 (the 2020 Notes), 5.875% Senior Notes due 2023 (the 2023 Notes), 4.50% Senior Notes due 2023 (the Euro Notes) and 6.125% Senior Notes due 2025 (the 2025 Notes and, together with the 2020 Notes, the 2023 Notes and the Euro Notes, the Notes), initially in the aggregate principal amount of $2,000,000,000 in respect of the 2020 Notes, in the aggregate principal amount of $3,250,000,000 in respect of the 2023 Notes, in the aggregate principal amount of 1,500,000,000 in respect of the Euro Notes and in the aggregate principal amount of $3,250,000,000 in respect of the 2025 Notes;
WHEREAS pursuant to Section 9.1 of the Indenture, the Trustee, the Company and the Guarantors are authorized to execute and deliver this Supplemental Indenture;
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company, the Guarantors and the Trustee mutually covenant and agree for the equal and ratable benefit of the holders of the Notes as follows:
1. Defined Terms. As used in this Supplemental Indenture, terms defined in the Indenture or in the preamble or recital hereto are used herein as therein defined. The words herein, hereof and hereby and other words of similar import used in this Supplemental Indenture refer to this Supplemental Indenture as a whole and not to any particular section hereof.
2. Agreement to Assume Obligations. Effective upon the Escrow Release, the Company hereby agrees to unconditionally assume the Escrow Issuers Obligations under the Notes and the Indenture on the terms and subject to the conditions set forth in the Indenture and to be bound by all other applicable provisions of the Indenture and the Notes and to perform all of the obligations and agreements of the Escrow Issuer under the Indenture.
3. Agreement to Guarantee. Effective upon the Escrow Release, the Guarantors agree, jointly and severally, to unconditionally guarantee the Companys Obligations under the Notes and the Indenture on the terms and subject to the conditions set forth in Article 10 of the Indenture and to be bound by all other applicable provisions of the Indenture and the Notes and to perform all of the obligations and agreements of a Note Guarantor under the Indenture.
4. Notices. All notices or other communications to the Company shall be given as provided in Section 11.2 of the Indenture.
5. Ratification of Indenture; Supplemental Indenture Part of Indenture. Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Supplemental Indenture shall form a part of the Indenture for all purposes, and every holder of Notes heretofore or hereafter authenticated and delivered shall be bound hereby.
6. Release of Obligations of Escrow Issuer. Effective upon the Escrow Release and the execution of this Supplemental Indenture, the Escrow Issuer is automatically released and discharged from all obligations under the Indenture and the Notes, without any further action on the part of the Escrow Issuer or the Trustee.
7. Governing Law. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW.
8. Trustee Makes No Representation. The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture. The recitals and statements herein are deemed to be those of the Company and the Guarantors and not of the Trustee.
9. Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement.
10. Effect of Headings. The Section headings herein are for convenience only and shall not effect the construction thereof.
IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the date first above written.
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]
COMPANY GUARANTORS: | ||||
VALEANT PHARMACEUTICALS INTERNATIONAL | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB INCORPORATED | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB HOLDINGS INCORPORATED | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Vice President and Treasurer | |||
SOLTA MEDICAL, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]
ATON PHARMA, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
CORIA LABORATORIES, LTD. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
DOW PHARMACEUTICAL SCIENCES, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]
OBAGI MEDICAL PRODUCTS, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Treasurer | |||
OMP, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Treasurer | |||
ONPHARMA INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Treasurer |
[Signature Page to Supplemental Indenture]
Signed by | ||||
Valeant Holdco 2 Pty Ltd (ACN 154 341 367) | ||||
in accordance with section 127 of the Corporations Act 2001 by two directors: | ||||
/s/ Robert R. Chai-Onn | /s/ Linda A. LaGorga | |||
Signature of director | Signature of director | |||
Robert R. Chai-Onn | Linda A. LaGorga | |||
Name of director (please print) | Name of director (please print) | |||
Signed by | ||||
Wirra Holdings Pty Limited (ACN 122 216 577) | ||||
in accordance with section 127 of the Corporations Act 2001 by two directors: | ||||
/s/ Robert R. Chai-Onn | /s/ Linda A. LaGorga | |||
Signature of director | Signature of director | |||
Robert R. Chai-Onn | Linda A. LaGorga | |||
Name of director (please print) | Name of director (please print) | |||
Signed by | ||||
Wirra Operations Pty Limited (ACN 122 250 088) | ||||
in accordance with section 127 of the Corporations Act 2001 by two directors: | ||||
/s Robert R. Chai-Onn | /s/ Linda A. LaGorga | |||
Signature of director | Signature of director | |||
Robert R. Chai-Onn | Linda A. LaGorga | |||
Name of director (please print) | Name of director (please print) |
[Signature Page to Supplemental Indenture]
Signed by | ||||
iNova Pharmaceuticals (Australia) Pty Limited (ACN 000 222 408) | ||||
in accordance with section 127 of the Corporations Act 2001 by two directors: | ||||
/s/ Robert R. Chai-Onn | /s/ Linda A. LaGorga | |||
Signature of director | Signature of director | |||
Robert R. Chai-Onn | Linda A. LaGorga | |||
Name of director (please print) | Name of director (please print) | |||
Signed by | ||||
Wirra IP Pty Limited (ACN 122 536 350) | ||||
in accordance with section 127 of the Corporations Act 2001 by two directors: | ||||
/s/ Robert R. Chai-Onn | /s/ Linda A. LaGorga | |||
Signature of director | Signature of director | |||
Robert R. Chai-Onn | Linda A. LaGorga | |||
Name of director (please print) | Name of director (please print) | |||
Signed by | ||||
iNova Sub Pty Limited (ACN 134 398 815) | ||||
in accordance with section 127 of the Corporations Act 2001 by two directors: | ||||
/s/ Robert R. Chai-Onn | /s/ Linda A. LaGorga | |||
Signature of director | Signature of director | |||
Robert R. Chai-Onn | Linda A. LaGorga | |||
Name of director (please print) | Name of director (please print) |
[Signature Page to Supplemental Indenture]
Signed by | ||||
Valeant Pharmaceuticals Australasia Pty Limited (ACN 001 083 352) | ||||
in accordance with section 127 of the Corporations Act 2001 by a director and secretary/director: | ||||
/s/ Robert R. Chai-Onn | /s/ Linda A. LaGorga | |||
Signature of director | Signature of director/secretary | |||
Robert R. Chai-Onn | Linda A. LaGorga | |||
Name of director (please print) | Name of director/secretary (please print) | |||
Signed by | ||||
DermaTech Pty Ltd (ACN 003 982 161) | ||||
in accordance with section 127 of the Corporations Act 2001 by a director and secretary/director: | ||||
/s/ Robert R. Chai-Onn | /s/ Howard B. Schiller | |||
Signature of director | Signature of director/secretary | |||
Robert R. Chai-Onn | Howard B. Schiller | |||
Name of director (please print) | Name of director/secretary (please print) |
[Signature Page to Supplemental Indenture]
Signed by | ||||
Private Formula International Holdings Pty Ltd (ACN 095 450 918) | ||||
in accordance with section 127 of the Corporations Act 2001 by a director and secretary/director: | ||||
/s/ Robert R. Chai-Onn | /s/ Howard B. Schiller | |||
Signature of director | Signature of director/secretary | |||
Robert R. Chai-Onn | Howard B. Schiller | |||
Name of director (please print) | Name of director/secretary (please print) | |||
Signed by | ||||
Private Formula International Pty Ltd (ACN 095 451 442) | ||||
in accordance with section 127 of the Corporations Act 2001 by a director and secretary/director: | ||||
/s/ Robert R. Chai-Onn | /s/ Howard B. Schiller | |||
Signature of director | Signature of director/secretary | |||
Robert R. Chai-Onn | Howard B. Schiller | |||
Name of director (please print) | Name of director/secretary (please print) |
[Signature Page to Supplemental Indenture]
Signed by | ||||
Ganehill Pty Ltd (ACN 065 261 538) | ||||
in accordance with section 127 of the Corporations Act 2001 by a director and secretary/director: | ||||
/s/ Robert R. Chai-Onn | /s/ Howard B. Schiller | |||
Signature of director | Signature of director/secretary | |||
Robert R. Chai-Onn | Howard B. Schiller | |||
Name of director (please print) | Name of director/secretary (please print) |
[Signature Page to Supplemental Indenture]
Signed by | ||||
Bausch & Lomb (Australia) Pty Ltd (ACN: 000 650 251) | ||||
in accordance with section 127 of the Corporations Act 2001 by a director and secretary/director: | ||||
/s/ Linda A. LaGorga | /s/ Ling Zeng | |||
Signature of director | Signature of director/secretary | |||
Linda A. LaGorga | Ling Zeng | |||
Name of director (please print) | Name of director/secretary (please print) |
[Signature Page to Supplemental Indenture]
HYTHE PROPERTY INCORPORATED | ||||
By: | /s/ Mauricio Zavala | |||
Name: | Mauricio Zavala | |||
Title: | Assistant Secretary |
[Signature Page to Supplemental Indenture]
VALEANT INTERNATIONAL BERMUDA | ||||
By: | /s/ Graham Jackson | |||
Name: | Graham Jackson | |||
Title: | Director | |||
VALEANT PHARMACEUTICALS NOMINEE BERMUDA | ||||
By: | /s/ Peter McCurdy | |||
Name: | Peter McCurdy | |||
Title: | President and Assistant Secretary |
[Signature Page to Supplemental Indenture]
PROBIÓTICA LABORATÓRIOS LTDA. | ||||
By: | /s/ Marcelo Noll Barboza | |||
Name: | Marcelo Noll Barboza | |||
Title: | Officer | |||
By: | /s/ Guilherme Maradei | |||
Name: | Guilherme Maradei | |||
Title: | Officer |
[Signature Page to Supplemental Indenture]
IOLAB CORPORATION | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Treasurer | |||
TECHNOLAS PERFECT VISION, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB PHARMA HOLDINGS CORP. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB CHINA, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB SOUTH ASIA, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB TECHNOLOGY CORPORATION | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Treasurer |
[Signature Page to Supplemental Indenture]
RHC HOLDINGS, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
SIGHT SAVERS, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB INTERNATIONAL, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
BAUSCH & LOMB REALTY CORPORATION. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Vice President and Treasurer | |||
ISTA PHARMACEUTICALS, LLC | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
VRX HOLDCO, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Chief Financial Officer and Treasurer |
[Signature Page to Supplemental Indenture]
VALEANT CANADA GP LIMITED | ||||
By: | /s/ Howard B. Schiller | |||
Name: | Howard B. Schiller | |||
Title: | Executive Vice President and Chief Financial Officer | |||
VALEANT CANADA S.E.C./VALEANT CANADA LP | ||||
By: | /s/ Howard B. Schiller | |||
Name: | Howard B. Schiller | |||
Title: | Executive Vice President and Chief | |||
Financial Officer | ||||
V-BAC HOLDING CORP. | ||||
By: | /s/ Robert R. Chai-Onn | |||
Name: | Robert R. Chai-Onn | |||
Title: | Vice President |
[Signature Page to Supplemental Indenture]
MEDICIS PHARMACEUTICAL CORPORATION | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
VALEANT PHARMACEUTICALS NORTH AMERICA LLC | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
DR. LEWINNS PRIVATE FORMULA INTERNATIONAL, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
PRINCETON PHARMA HOLDINGS, LLC | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
PRIVATE FORMULA CORP. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]
RENAUD SKIN CARE LABORATORIES, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]
VALEANT BIOMEDICALS, INC. | ||||
By: | /s/ Howard B. Schiller | |||
Name: | Howard B. Schiller | |||
Title: | Chief Financial Officer and Treasurer | |||
OCEANSIDE PHARMACEUTICALS, INC. | ||||
By: | /s/ Howard B. Schiller | |||
Name: | Howard B. Schiller | |||
Title: | Chief Financial Officer and Treasurer | |||
BIOVAIL AMERICAS CORP. | ||||
By: | /s/ Howard B. Schiller | |||
Name: | Howard B. Schiller | |||
Title: | Chief Financial Officer and Treasurer | |||
ORAPHARMA, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer | |||
ORAPHARMA TOPCO HOLDINGS, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]
PRESTWICK PHARMACEUTICALS, INC. | ||||
By: | /s/ Howard B. Schiller | |||
Name: | Howard B. Schiller | |||
Title: | Chief Financial Officer and Treasurer |
[Signature Page to Supplemental Indenture]
LABORATOIRE CHAUVIN S.A.S. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda LaGorga | |||
Title: | General Manager | |||
BAUSCH & LOMB FRANCE S.A.S. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda LaGorga | |||
Title: | General Manager | |||
BCF S.A.S. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda LaGorga | |||
Title: | General Manager | |||
CHAUVIN OPSIA S.A.S. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda LaGorga | |||
Title: | General Manager |
[Signature Page to Supplemental Indenture]
VALEANT PHARMA HUNGARY LLC | ||||
By: | /s/ István Langer | |||
Name: | István Langer | |||
Title: | Managing Director | |||
VALEANT PHARMA HUNGARY LLC | ||||
By: | /s/ Zoltán Gábor | |||
Name: | Zoltán Gábor | |||
Title: | Managing Director |
[Signature Page to Supplemental Indenture]
VALEANT PHARMACEUTICALS IRELAND | ||||
By: | /s/ Graham Jackson | |||
Name: | Graham Jackson | |||
Title: | Director | |||
VALEANT HOLDINGS IRELAND | ||||
By: | /s/ Graham Jackson | |||
Name: | Graham Jackson | |||
Title: | Director |
[Signature Page to Supplemental Indenture]
B.L.J. COMPANY, LTD. | ||||
By: | /s/ Ian Dolling | |||
Name: | Ian Dolling | |||
Title: | Representative Director and President |
[Signature Page to Supplemental Indenture]
AB SANITAS | ||||
By: | /s/ Karol Michalak | |||
Name: | Karol Michalak | |||
Title: | General Manager |
[Signature Page to Supplemental Indenture]
BIOVAIL INTERNATIONAL S.Á.R.L. | ||||
By: | /s/ Giuseppe di Modica | |||
Name: | Giuseppe di Modica | |||
Title: | Manager | |||
VALEANT PHARMACEUTICALS LUXEMBOURG S.Á.R.L. | ||||
By: | /s/ Giuseppe di Modica | |||
Name: | Giuseppe di Modica | |||
Title: | Manager | |||
VALEANT INTERNATIONAL LUXEMBOURG S.Á.R.L. | ||||
By: | /s/ Giuseppe di Modica | |||
Name: | Giuseppe di Modica | |||
Title: | Manager | |||
BAUSCH & LOMB LUXEMBOURG S.Á.R.L. | ||||
By: | /s/ Giuseppe di Modica | |||
Name: | Giuseppe di Modica | |||
Title: | Manager |
[Signature Page to Supplemental Indenture]
UCYCLYD PHARMA, INC. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]
VALEANT EUROPE B.V. | ||||
By: | /s/ Robert Meijer | |||
Name: | Robert Meijer | |||
Title: | Attorney-in-Fact | |||
BAUSCH & LOMB B.V. | ||||
By: | /s/ Robert Meijer | |||
Name: | Robert Meijer | |||
Title: | Attorney-in-Fact | |||
BAUSCH + LOMB OPS B.V. | ||||
By: | /s/ Robert Meijer | |||
Name: | Robert Meijer | |||
Title: | Attorney-in-Fact |
[Signature Page to Supplemental Indenture]
PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA S.A. | ||||
By: | /s/ Marcin Wnukowski | |||
Name: | Marcin Wnukowski | |||
Title: | Attorney-in-Fact | |||
VALEANT SP.Z O. O. | ||||
By: | /s/ Marcin Wnukowski | |||
Name: | Marcin Wnukowski | |||
Title: | Attorney-in-Fact | |||
VP VALEANT SP. Z O.O.SP.J. | ||||
By: | /s/ Marcin Wnukowski | |||
Name: | Marcin Wnukowski | |||
Title: | Attorney-in-Fact | |||
VALEANT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SP.J. | ||||
By: | /s/ Marcin Wnukowski | |||
Name: | Marcin Wnukowski | |||
Title: | Attorney-in-Fact |
[Signature Page to Supplemental Indenture]
PHARMASWISS D.O.O., BEOGRAD | ||||
By: | /s/ Dejan Antonić | |||
Name: | Dejan Antonić | |||
Title: | General Manager | |||
(corporate stamp) |
[Signature Page to Supplemental Indenture]
PHARMASWISS D.O.O. | ||||
By: | /s/ Senahil Asanagić | |||
Name: | Senahil Asanagić | |||
Title: | Director |
[Signature Page to Supplemental Indenture]
INOVA PHARMACEUTICALS PROPRIETARY LIMITED | ||||
By: | /s/ Howard B. Schiller | |||
Name: | Howard B. Schiller | |||
Title: | Director |
[Signature Page to Supplemental Indenture]
PHARMASWISS SA | ||||
By: | /s/ Matthias Courvoisier | |||
Name: | Matthias Courvoisier | |||
Title: | Director |
[Signature Page to Supplemental Indenture]
Executed by BAUSCH & LOMB U.K. LIMITED, acting by: |
/s/ Linda A. LaGorga |
Director |
Name of director: Linda A. LaGorga in the presence of: |
/s/ Kaleena Nguyen |
Name of witness: Kaleena Nguyen |
Address: |
Occupation: |
[Signature Page to Supplemental Indenture]
BAUSCH & LOMB IOM S.P.A. | ||||
By: | /s/ Linda A. LaGorga | |||
Name: | Linda A. LaGorga | |||
Title: | Director |
[Signature Page to Supplemental Indenture]
SIGNED for and on behalf | ) | |||||||||
of VALEANT PHARMACEUTICALS NEW ZEALAND LIMITED | ) ) | /s/ Howard Schiller | /s/ Robert R. Chai-Onn | |||||||
| ||||||||||
Name: | Howard Schiller | Name: | Robert R. Chai-Onn | |||||||
Title: | Director | Title: | Director |
[Signature Page to Supplemental Indenture]
INOVA PHARMACEUTICALS (SINGAPORE) PTE LIMITED | ||||
By: | /s/ Howard Schiller | |||
Name: | Howard Schiller | |||
Title: | Director |
[Signature Page to Supplemental Indenture]
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee | ||||
By: | /s/ Jonathan Glover | |||
Name: | Jonathan Glover | |||
Title: | Vice President |
[Signature Page to Supplemental Indenture]
Acknowledged and Agreed by: | ||||
VRX ESCROW CORP. | ||||
By: | /s/ Linda LaGorga | |||
Name: | Linda LaGorga | |||
Title: | Senior Vice President and Treasurer |
[Signature Page to Supplemental Indenture]